156 related articles for article (PubMed ID: 7550861)
21. Nucleation of cholesterol from vesicles isolated from bile of patients with and without cholesterol gallstones.
Harvey PR; Somjen G; Lichtenberg MS; Petrunka C; Gilat T; Strasberg SM
Biochim Biophys Acta; 1987 Sep; 921(2):198-204. PubMed ID: 3651484
[TBL] [Abstract][Full Text] [Related]
22. No pathophysiologic relationship of soluble biliary proteins to cholesterol crystallization in human bile.
Wang DQ; Cohen DE; Lammert F; Carey MC
J Lipid Res; 1999 Mar; 40(3):415-25. PubMed ID: 10064729
[TBL] [Abstract][Full Text] [Related]
23. Isolation and purification of human biliary vesicles with potent cholesterol-nucleation-promoting activity.
Miquel JF; Rigotti A; Rojas E; Brandan E; Nervi F
Clin Sci (Lond); 1992 Feb; 82(2):175-80. PubMed ID: 1311655
[TBL] [Abstract][Full Text] [Related]
24. Effect of cholesterol nucleation-promoting activity on cholesterol solubilization in model bile.
Groen AK; Ottenhoff R; Jansen PL; van Marle J; Tytgat GN
J Lipid Res; 1989 Jan; 30(1):51-8. PubMed ID: 2918249
[TBL] [Abstract][Full Text] [Related]
25. Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae.
Ginanni Corradini S; Arancia G; Calcabrini A; Della Guardia P; Baiocchi L; Nistri A; Giacomelli L; Angelico M
J Hepatol; 1995 Jun; 22(6):642-57. PubMed ID: 7560858
[TBL] [Abstract][Full Text] [Related]
26. Nonmucous glycoproteins as pronucleating agents.
Groen AK
Hepatology; 1990 Sep; 12(3 Pt 2):189S-192S; discussion 192S-194S. PubMed ID: 2210648
[TBL] [Abstract][Full Text] [Related]
27. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile.
Hussaini SH; Pereira SP; Murphy GM; Dowling RH
Hepatology; 1995 Dec; 22(6):1735-44. PubMed ID: 7489982
[TBL] [Abstract][Full Text] [Related]
28. Bile concentration promotes nucleation of cholesterol monohydrate crystals by increasing the cholesterol concentration in the vesicles.
Van Erpecum KJ; Stolk MF; van den Broek AM; Renooij W; van de Heijning BJ; van Berge Henegouwen GP
Eur J Clin Invest; 1993 May; 23(5):283-8. PubMed ID: 8354334
[TBL] [Abstract][Full Text] [Related]
29. Inhibition and promotion of cholesterol crystallization by protein fractions from normal human gallbladder bile.
Busch N; Matiuck N; Sahlin S; Pillay SP; Holzbach RT
J Lipid Res; 1991 Apr; 32(4):695-702. PubMed ID: 1856612
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of cholesterol transport in bile from patients with and without cholesterol gallstones.
Pattinson NR; Willis KE; Frampton CM
J Lipid Res; 1991 Feb; 32(2):205-14. PubMed ID: 2066657
[TBL] [Abstract][Full Text] [Related]
31. Deoxycholic acid in gall bladder bile does not account for the shortened nucleation time in patients with cholesterol gall stones.
Noshiro H; Chijiiwa K; Makino I; Nakano K; Hirota I
Gut; 1995 Jan; 36(1):121-5. PubMed ID: 7890215
[TBL] [Abstract][Full Text] [Related]
32. Activity of cholesterol in human gallbladder bile in relation to nucleation of cholesterol monohydrate crystals.
Noshiro H; Chijiiwa K; Hirota I
Clin Chim Acta; 1992 Feb; 205(3):167-79. PubMed ID: 1576744
[TBL] [Abstract][Full Text] [Related]
33. Lectin binding characteristics of a cholesterol nucleation promoting protein.
Harvey PR; Upadhya A; Toth JL; Strasberg SM
Clin Chim Acta; 1989 Nov; 185(2):185-9. PubMed ID: 2624998
[No Abstract] [Full Text] [Related]
34. Cholesterol nucleation in bile.
Holzbach RT
Ital J Gastroenterol; 1995 Mar; 27(2):101-5. PubMed ID: 7579590
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol nucleation-influencing activity in T-tube bile.
Groen AK; Stout JP; Drapers JA; Hoek FJ; Grijm R; Tytgat GN
Hepatology; 1988; 8(2):347-52. PubMed ID: 3356415
[TBL] [Abstract][Full Text] [Related]
36. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
[TBL] [Abstract][Full Text] [Related]
38. The comparative potency of cholesterol crystallization-effector proteins in supersaturated model bile systems: association with vesicle transformation.
Hattori Y; Tazuma S; Yamashita G; Kajiyama G
J Gastroenterol Hepatol; 1998 Nov; 13(11):1161-70. PubMed ID: 9870806
[TBL] [Abstract][Full Text] [Related]
39. Solitary versus multiple gallstones: the importance of total biliary protein concentration and other factors.
Tudyka J; Kratzer W; Kuhn K; Mason R; Wechsler JG; Adler G
Hepatogastroenterology; 1995; 42(5):638-44. PubMed ID: 8751227
[TBL] [Abstract][Full Text] [Related]
40. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn's disease compared to patients with ulcerative colitis.
Keulemans YC; Mok KS; Slors JF; Brink MA; Gouma DJ; Tytgat GN; Groen AK
J Hepatol; 1999 Oct; 31(4):685-91. PubMed ID: 10551393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
